José Ignacio Nolazco

Dr. José Ignacio Nolazco

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Journal of Clinical and Translational Research
Verified
Journal Article
Open access
JNJosé Ignacio Nolazco
José Ignacio Nolazco
SCSteven Lee Chang
Steven Lee Chang

22 April 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
JNJosé Ignacio Nolazco
José Ignacio Nolazco
LMLorelei A. Mucci
Lorelei A. Mucci
RSRoman Sosnowski
Roman Sosnowski
KPKrzysztof Przewoźniak
Krzysztof Przewoźniak
SCSteven L. Chang
Steven L. Chang
CNCosimo De Nunzio
Cosimo De Nunzio

11 April 2023 in Current Urology
Verified
Journal Article
Open access
JNJosé Ignacio Nolazco
José Ignacio Nolazco

20 February 2023 in Urologic Clinics of North America
Verified
Journal Article
Closed access
JNJosé Ignacio Nolazco
José Ignacio Nolazco
SSSimon John Christoph Soerensen
Simon John Christoph Soerensen
BCBenjamin I. Chung
Benjamin I. Chung

4 January 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JNJosé Ignacio Nolazco
José Ignacio Nolazco
BRBernard A Rosner
Bernard A Rosner
EREmily H Roebuck
Emily H Roebuck
CBCristiane Decat Bergerot
Cristiane Decat Bergerot
ERElke Rammant
Elke Rammant
SCSteven Lee Chang
Steven Lee Chang
Introduction: The Health-Related Quality of Life (HRQoL) often declines among cancer survivors due to many factors. Some cancer patients who smoke before the cancer diagnosis continue this harmful habit, potentially contributing to a more significant decline in their HRQoL. Therefore, this study investigates the association between smoking status and HRQoL in cancer survivors.Methods: We conducted a cross-sectional study utilizing self-reported cancer history from 39,578 participants of the Behavioral Risk Factor Surveillance System (BRFSS) database, leveraging 2016 and 2020 year questionaries. A multidimensional composite outcome was created to assess HRQoL, integrating four distinct dimensions - general health, mental health, physical health, and activity limitations. After accounting for the complex survey design, logistic regression models were used to analyze the association between smoking status and poor HRQoL, adjusting for demographic, socioeconomic, and health-related confounders.Results: Our study found that, after adjusting for potential confounders, current smokers exhibited a significantly poorer HRQoL than never smokers (OR 1.65, 95%CI 1.40-1.93). Furthermore, former smokers showed a poorer HRQoL than never smokers; however, this association was not as strong as current smokers (OR 1.22, 95%CI 1.09-1.38).Conclusion: Our findings highlight the adverse association of smoking with poor HRQoL in cancer survivors, underscoring the importance of healthcare professionals prioritizing smoking cessation and providing tailored interventions to support this goal.

20 November 2023 in Cancer Medicine
Verified
Journal Article
Open access
JNJosé Ignacio Nolazco
José Ignacio Nolazco
YTYuzhe Tang
Yuzhe Tang
KAKhalid Y. Alkhatib
Khalid Y. Alkhatib
AKAndrew J. King
Andrew J. King
MMMatthew Mossanen
Matthew Mossanen
SCSteven Lee Chang
Steven Lee Chang
Background: Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco-related cancer survivors.Methods: We conducted a cross-sectional analysis of data from cancer survivors with a smoking history using the Behavioral Risk Factor Surveillance System (BRFSS) database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016-2020 period. We accounted for complex survey design and used sampling weights to obtain a nationwide representative sample. We employed modified Poisson regression adjusting for age, gender, education, income, race, marital status, and medical specialty.Results: We analyzed 19,855 cancer survivors with a current or past history of tobacco use, of whom 5222 (26,3%) self-reported to be current smokers. Patients with urological and gynecological tobacco-related malignancies had a higher relative risk (RR) of being current smokers with a RR of 1.30 (95% confidence interval, 1.12-1.51) and 1.25 (95% confidence interval, 1.12-1.39) respectively. Malignant Hematology had the lowest RR of smoking status among all other specialties RR 0.85 (95% confidence interval, 0.59-1.21).Conclusions: Continuing smoking rates among tobacco-related cancer survivors were different between specialties. One in four cancer survivors were current smokers; this emphasizes health professionals' paramount role in tobacco cessation counseling.